Ramsey Baghdadi
Latest From Ramsey Baghdadi
Flaws Of ‘Virtual’ Advisory Committees Highlighted At Aducanumab Panel
The intensely negative advisory committee for Biogen’s proposed Alzheimer’s therapy was a shocker. Would it have happened if US FDA had been able to convene an in-person event instead of a ‘virtual’ one?
The Greatest FDA Advisory Committees, Part III: The Power of The Patients
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years.
The Greatest FDA Advisory Committees, Part II: The Birth Of The ‘Pazdur Moment’
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years. This is Part II in the series.
The Greatest US FDA Advisory Committees: A Look Back At Tumult And Turning Points
With two landmark advisory committee meetings coming up, the Pink Sheet reflects on some of the most memorable panel meetings over the last 20 years.
Go Beyond The Vial: Medicare Policy Experts Urge Big Thinking On Drug Pricing
NASEM is expected to issue a highly anticipated report in early 2021 on solutions to address Rx vial drug wastage.
US FDA’s Career Leaders Quietly Emerge As Effective Operators In COVID-19 Response
FDA medical review leaders have been remarkable on balancing the two challenges of finding treatments for COVID-19 and keeping everything else running on time.